FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3211303 · Received July 8, 2013

Report

Report Number
2124215-2013-07982
Event Type
Injury
Date Received
July 8, 2013
Date of Event
May 6, 2013
Report Date
May 13, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS OF THIS DATE, THIS LEAD REMAINS IMPLANTED AND IN SERVICE. WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS EVENT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

APPROXIMATELY ONE WEEK LATER, A REVISION PROCEDURE WAS PERFORMED. THIS LEAD WAS SURGICALLY ABANDONED AND REPLACED. THE REPLACEMENT LEAD WAS IMPLANTED FROM THE PATIENT'S RIGHT SIDE DUE TO THE LEFT SIDE CLOSED VENOUS ACCESS. IN ADDITION, THE DEVICE WAS ALSO REPLACED WITH INDUCTION TESTING AND SUCCESSFUL CONVERSION. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A FOLLOW UP VISIT, THIS RIGHT VENTRICULAR LEAD DISPLAYED LOW OUT OF RANGE IMPEDANCE MEASUREMENTS. TRENDING REVEALED THE IMPEDANCE MEASUREMENTS HAVE DECREASED DURING THE PAST FEW MONTHS. IN ADDITION, SIX EPISODES OF NOISE WERE DISPLAYED. SHOCK IMPEDANCE MEASUREMENTS WERE STABLE AND WITHIN NORMAL RANGE. A LEAD REVISION IS INTENDED. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE PATIENT WITH THIS LEAD IS NOT PACEMAKER DEPENDENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310968 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0148

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R